Background The plasma concentration of apolipoprotein E might be an important risk factor for various chronic diseases, including coronary heart disease.
Objective To investigate the role of lifestyle-related factors in determining concentrations of apolipoprotein E.
Methods The independent effects of age and several lifestyle-related factors [body mass index (BMI), smoking, consumption of alcohol, physical activity, educational level and poly-unsaturated: Saturated fatty acid intake ratio in diet] on the apolipoprotein E concentration were assessed for a sample of 757 middle-aged working men. Multiple log-linear regression models were fitted with additional correction for the apolipoprotein E polymorphism.
Results The overall mean plasma concentration of apolipoprotein E was 3.44 mg/dl with mean levels varying from 2.42 mg/dl in men with the E4/4 phenotype to 8.32 mg/dl in men in the E2/2 group. In multivariate analysis apolipoprotein E levels were found to be significantly positively correlated to BMI (P < 0.0001) and consumption of alcohol (P = 0.04). The effect of age on the apolipoprotein E concentration was significantly quadratic (P = 0.02) with highest levels found in the men aged 40-44 years (levels 13.3% greater than those in the men aged 35-39 years). Subjects with BMI in the range 27-30 kg/m2 had on average a 16.4% higher apolipoprotein E concentration than did men in the group with BMI lower than 23 kg/m2. This adjusted proportional increase amounted to 22.6% for the severely obese subjects (BMI > 30 kg/m2). The independent effect of current smoking was only of borderline statistical significance.
Conclusions These results indicate that age and lifestyle-related factors, such as BMI and to a lesser extent consumption of alcohol and smoking, should be taken into account as possible confounders in the study of the plasma concentration of apolipoprotein E as a risk factor for coronary heart disease.
WeisgraberKH.Apolipoprotein E: Structure-function relationships. In: SchumackerVN (editor): Advances in protein chemistry. Volume 45. New York: Academic Press; 1994. pp. 249–302.
3.
UtermannG.Apolipoprotein E polymorphism in health and disease. Am Heart J1987; 113: 433–439.
4.
DavignonJGreggRESingCF.Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis1988; 8: 1–21.
5.
SiestGPillotTRégis-BaillyALeininger-MullerBSteinmetzJGalteauM-MApolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin Chem1995; 41: 1068–1086.
6.
MahleyRW.Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science1988; 240: 622–630.
7.
SingCFDavignonJ.Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet1985; 37: 268–285.
8.
BoerwinkleEUtermannG.Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B and cholesterol metabolism. Am J Hum Genet1988; 42: 104–112.
9.
MurosMRodriguez-FerrerC.Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis1996; 121: 13–21.
10.
HallmanDMBoerwinkleESahaNSandholzerCMenzelHJCsazarAThe apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am J Hum Genet1991; 49: 338–349.
11.
LucGBardJ-MArveilerDEvansACambouJ-PBinghamAImpact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb1994; 14: 1412–1419.
12.
TiretLde KnijffPMenzelH-JEhnholmCNicaudVHavekesL.ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. Arterioscler Thromb1994; 14: 1617–1624.
13.
BraeckmanLDe BacquerDRosseneuMDe BackerG.Apolipoprotein E polymorphism in middle-aged Belgian men. Phenotype distribution and relation to serum lipids and lipoproteins. Atherosclerosis1996; 120: 67–73.
14.
LehtimäkiTMoilanenTPorkkaKAkerblomHKRönnemaaTRäsänenLAssociation between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: The Cardiovascular Risk in Young Finns Study. J Lipid Res1995; 36: 653–661.
15.
SchaeferEJLamon-FavaSJohnsonSOrdovasJMSchaeferMMCastelliWPEffects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: Results from the Framingham Offspring Study. Arterioscler Thromb1994; 14: 1105–1113.
16.
ReillySLFerrelRESingCF.The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III: Correlates and covariances. Am J Hum Genet1994; 55: 1001–1018.
17.
HavekesLde KnijffPReisiegelUHavingaJSmitMKlasenE.A rapid micro-method for apolipoprotein E phenotyping directly in serum. J Lipid Res1987; 28: 445–463.
18.
BuryJVercaemstRRosseneuMBelpaireF.Apolipoprotein E quantified by enzyme-linked immunosorbent assay. Clin Chem1986; 32: 265–270.
19.
SAS/STAT user's guide, release 6-04 edition. Cary, NC: SAS Institute Inc.; 1988.
20.
LecomteEHerbethBPailleFSteinmetzJArturYSiestG.Changes in apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: Determinant effect on heart disease?Clin Chem1996; 42: 1666–1675.
21.
DesprésJ-PMoorjaniSLupienPJTremblayANadeauABouchardC.Regional distribution of body fat, plasma lipoproteins and cardiovascular disease. Arteriosclerosis1990; 10: 497–511.
22.
Régis-BaillyAVisvikisSSteinmetzJFournierBGueguenRSiestG.Effects of apo B and apo E polymorphisms on lipid and lipoprotein concentrations after a test meal. Clin Chem Acta1996; 253: 127–143.
23.
TanMHDickinsonMAAlbersJJHavelRJCheungMCVigneJP.The effect of a high cholesterol and saturated fat diet on serum high-density lipoprotein cholesterol, apolipoprotein A-l, and apoprotein E levels in normolipidemic humans. Am J Clin Nutr1980; 33: 2559–2565.
24.
HiranoKMatsuzawaYSakaiNNozakiSFunahashiTYamashitaSPolydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcoholic drinkers in association with marked reduction of cholesteryl ester transfer protein activity. Metabolism1992; 41: 1313–1318.
25.
WehrHBednarska-MakarukMSzackaE.Apolipoprotein E in alcoholics. Alcohol Alcohol1995; 30: 27–30.
26.
Marques-VidalPCambouJ-PNicaudVLucGEvansAArveilerDCardiovascular risk factors and alcohol consumption in France and Northern Ireland. Atherosclerosis1995; 115: 225–232.
27.
LinRMillerBAKellyTJ.Concentrations of apolipoprotein AI, AII and E in plasma and lipoprotein fractions of alcoholic patients: Gender differences in the effect of alcohol. Hepatology1995; 21: 942–949.
28.
JaidMBenkiraneSSteinmetzJGueguenRGalteauMM.Effets du tabagisme sur les lipides, les apolipoprotéines et les particles lipoprotéiques. In: GalteauMMSiestGHennyJ (editors): Biologie prospective.Paris: John Libbey Eurotext; 1993. pp. 569–574.
29.
SuperkoHR.Exercise and lipoprotein metabolism. J Cardiovasc Risk1995; 2: 310–315.
30.
SeipRLMoulinPCockeTTallAKohrtWMMankowitzKExercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb1993; 13: 1359–1367.
